脑心通干预糖尿病患者心脑血管病疗效评估
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:


Evaluation of Naoxintong Efficacy for Treating Cardiovascular Events in Diabetic Patients
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:社区应用不同疗法治疗糖尿病患者,评估应用脑心通胶囊针对预防糖尿病心脑血管意外、实验室指标及干预颈动脉内层中膜厚度的临床疗效。方法:67例糖尿病患者分为2组予延续西药降糖、降脂等治疗。中药组应用脑心通胶囊治疗,对照组不应用中药汤剂或中成药治疗。持续治疗1年后从心脑血管不良事件、颈动脉彩超结果及血糖、血脂、糖化血红蛋白等生化指标等方面,评估其治疗效果。结果:与治疗前相比,中药组与对照组血脂较治疗前差异有统计学意义(P<0.05),且2组间比较差异有统计学意义(P<0.05)。中药组在IMT、血糖、糖化血红蛋白等指标方面治疗前后比较差异有统计学意义(P<0.05),而对照组治疗前后比较差异无统计学意义(P>0.05),2组比较差异有统计学意义(P<0.05),中药组心脑血管不良事件较对照组少。结论:社区的糖尿病患者应用脑心通胶囊治疗有益于血糖、血脂控制,血管内皮保护及预防心脑血管不良事件。

    Abstract:

    Abstract Objective: To observe cardiovascular events,changes of laboratory parameters,and carotid internal media thickness in diabetic patients applied with different treatment regimens.Methods:Sixty-seven patients were divided into 2 groups,both groups were treated with western medicines,the Chinese medicine group was treated with Naoxintong in addition.After 1 years of continuous treatment,therapeutic effect was evaluated based on incidence of cardiovascular events,IMT, blood glucose and lipids,glycated hemoglobin and other biochemical indicators.Results:There were significant blood lipid differences after treatment in both treatment groups (P<0.05),and the difference was significant between 2 groups (P<0.05).There was statistical significance before and after treatment in Chinese medicine group in IMT,blood glucose,glycosylated hemoglobin protein index (P<0.05),while the control group before and after treatment had no significant difference (P>0.05),there was significant difference between 2 groups (P<0.05).The Chinese medicine group had less cardiovascular event incidence compared with the control group.Conclusion:Naoxintong has good effect for treating blood glucose and blood lipids which helps to prevent incidence of cardiovascular events in diabetic patients.

    参考文献
    相似文献
    引证文献
引用本文

刘 焱.脑心通干预糖尿病患者心脑血管病疗效评估[J].世界中医药,2014,9(11).

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2012-11-21
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2015-01-05
  • 出版日期:
文章二维码